The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Depletion of multiple high‐abundance proteins improves protein profiling capacities of human serum and plasma
Abstract
Systematic detection of low‐abundance proteins in human blood that may be putative disease biomarkers is complicated by an extremely wide range of protein abundances. Hence, depletion of major proteins is one potential strategy for enhancing detection sensitivity in serum or plasma. This study compared a recently commercialized HPLC column containing antibodies to six of the most abundant blood proteins (“Top‐6 depletion”) with either older Cibacron blue/Protein A or G depletion methods or no depletion. In addition, a prototype spin column version of the HPLC column and an alternative prototype two antibody spin column were evaluated. The HPLC polyclonal antibody column and its spin column version are very promising methods for substantially simplifying human serum or plasma samples. These columns show the lowest nonspecific binding of the depletion methods tested. In contrast other affinity methods, particularly dye‐based resins, yielded many proteins in the bound fractions in addition to the targeted proteins. Depletion of six abundant proteins removed about 85% of the total protein from human serum or plasma, and this enabled 10‐ to 20‐fold higher amounts of depleted serum or plasma samples to be applied to 2‐D gels or alternative protein profiling methods such as protein array pixelation. However, the number of new spots detected on 2‐D gels was modest, and most newly visualized spots were minor forms of relatively abundant proteins. The inability to detect low‐abundance proteins near expected 2‐D staining limits was probably due to both the highly heterogeneous nature of most plasma or serum proteins and masking of many low‐abundance proteins by the next series of most abundant proteins. Hence, non2‐D methods such as protein array pixelation are more promising strategies for detecting lower abundance proteins after depleting the six abundant proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schägger, H., & von Jagow, G. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90587-2 · Cited by 11,444
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Characterization of the Low Molecular Weight Human Serum Proteome
Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J., Conrads, T. P., & Veenstra, T. D. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300031-mcp200 · Cited by 860
Toward a Human Blood Serum Proteome
Adkins, J. N., Varnum, S. M., Auberry, K. J., Moore, R. J., Angell, N. H., Smith, R. D., Springer, D. L., & Pounds, J. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200066-mcp200 · Cited by 793
Pieper, R., Gatlin, C. L., Makusky, A. J., Russo, P. S., Schatz, C. R., Miller, S. S., Su, Q., McGrath, A. M., Estock, M. A., Parmar, P. P., et al. (2003) · PROTEOMICS · doi:10.1002/pmic.200300449 · Cited by 518
Isolation of albumin from whole human plasma and fractionation of albumin-depleted plasma
Travis, J., Bowen, J., Tewksbury, D., Johnson, D., & Pannell, R. (1976) · Biochemical Journal · doi:10.1042/bj1570301 · Cited by 398
Pieper, R., Su, Q., Gatlin, C. L., Huang, S., Anderson, N. L., & Steiner, S. (2003) · PROTEOMICS · doi:10.1002/pmic.200390057 · Cited by 356
Hochstrasser, D. F., Patchornik, A., & Merril, C. R. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90208-4 · Cited by 306
Görg, A., Obermaier, C., Boguth, G., & Weiss, W. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19990101)20:4/5<712::aid-elps712>3.0.co;2-y · Cited by 247
Efficient and Specific Removal of Albumin from Human Serum Samples
Steel, L. F., Trotter, M. G., Nakajima, P. B., Mattu, T. S., Gonye, G., & Block, T. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300026-mcp200 · Cited by 212
An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum
Ahmed, N., Barker, G., Oliva, K., Garfin, D., Talmadge, K., Georgiou, H., Quinn, M., & Rice, G. (2003) · PROTEOMICS · doi:10.1002/pmic.200300465 · Cited by 197
Carboxypeptidase N: a pleiotropic regulator of inflammation
Matthews, K. W., Mueller-Ortiz, S. L., & Wetsel, R. A. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.002 · Cited by 185
Mining biomarkers in human sera using proteomic tools
Zhang, R., Barker, L., Pinchev, D., Marshall, J., Rasamoelisolo, M., Smith, C., Kupchak, P., Kireeva, I., Ingratta, L., & Jackowski, G. (2004) · PROTEOMICS · doi:10.1002/pmic.200300495 · Cited by 184
Chertov, O., Biragyn, A., Kwak, L. W., Simpson, J. T., Boronina, T., Hoang, V. M., Prieto, D. A., Conrads, T. P., Veenstra, T. D., & Fisher, R. J. (2004) · PROTEOMICS · doi:10.1002/pmic.200300677 · Cited by 171
Gianazza, E., & Arnaud, P. (1982) · Biochemical Journal · doi:10.1042/bj2010129 · Cited by 163
Proteomic approaches to biomarker discovery in prostate and bladder cancers
Adam, B.-L., Vlahou, A., Semmes, O. J., & Wright, Jr. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200110)1:10<1264::aid-prot1264>3.0.co;2-r · Cited by 162
Omenn, G. S. (2004) · PROTEOMICS · doi:10.1002/pmic.200300686 · Cited by 136
Sample preparation of human serum for the analysis of tumor markers
Govorukhina, N. I., Keizer-Gunnink, A., van der Zee, A. G. J., de Jong, S., de Bruijn, H. W. A., & Bischoff, R. (2003) · Journal of Chromatography A · doi:10.1016/s0021-9673(03)00921-x · Cited by 125
Wang, Y. Y., Cheng, P., & Chan, D. W. (2003) · PROTEOMICS · doi:10.1002/pmic.200390036 · Cited by 108
Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry
Maccarrone, G., Milfay, D., Birg, I., Rosenhagen, M. C., Holsboer, F., Grimm, R., Bailey, J. M., Zolotarjova, N. I., & Turck, C. W. (2004) · Electrophoresis · doi:10.1002/elps.200305909 · Cited by 94
Bijl, M., Bootsma, H., van der Geld, Y., Limburg, P. C., Kallenberg, C. G. M., & van Rijswijk, M. H. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2002.004796 · Cited by 41
Cited by
Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W., Menon, R., Hermjakob, H., Apweiler, R., Haab, B. B., Simpson, R. J., Eddes, J. S., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200500358 · Cited by 787
Self-citationMultiplexed protein measurement: technologies and applications of protein and antibody arrays
Kingsmore, S. F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2006 · Cited by 715
Human body fluid proteome analysis
Hu, S., Loo, J. A., & Wong, D. T. (2006) · PROTEOMICS · doi:10.1002/pmic.200600284 · Cited by 533
Depletion of Abundant Plasma Proteins and Limitations of Plasma Proteomics
Tu, C., Rudnick, P. A., Martinez, M. Y., Cheek, K. L., Stein, S. E., Slebos, R. J. C., & Liebler, D. C. (2010) · Journal of Proteome Research · doi:10.1021/pr100646w · Cited by 390
Targeted proteomic strategy for clinical biomarker discovery
Schiess, R., Wollscheid, B., & Aebersold, R. (2009) · Molecular Oncology · doi:10.1016/j.molonc.2008.12.001 · Cited by 373
Metadata
- Authors
- Echan, L. A., Tang, H., Ali‐Khan, N., Lee, K., & Speicher, D. W.
- Venue
- PROTEOMICS
- Publisher
- Wiley
- Published
- 2005-08
- Volume
- 5
- Issue
- 13
- Pages
- 3292-3303
- ISSN
- 1615-9853 (ISSN-L)
- 1615-9861
- OpenAlex
- W2126383455
- Cited by
- 353
- References
- 21
- FWCI
- 15.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.